Emerging Modulators of TMEM16A and Their Therapeutic Potential

Overview

Journal J Membr Biol

Date 2021 Jul 15

PMID 34263350

Citations 5

Authors

Anqi Hao

Shuai Guo

Sai Shi

Xuzhao Wang

Yong Zhan

Yafei Chen

Hailong An

Affiliations

Soon will be listed here.

Abstract

Calcium-activated chloride channels (CaCCs) are widespread chloride channels which rely on calcium activation to perform their functions. In 2008, TMEM16A (also known as anoctamin1, ANO1) was identified as the molecular basis of the CaCCs, which provided the possibility to study the physiological function of CaCCs. TMEM16A is widely expressed in various cells and controls basic physiological functions, including neuronal and cardiac excitability, nerve transduction, smooth muscle contraction, epithelial Cl secretion and fertilization. However, the abnormal function of TMEM16A may cause a variety of diseases, including asthma, gastrointestinal motility disorder and various cancers. Therefore, TMEM16A is a putative drug target for many diseases, and it is important to determine specific and efficient modulators of TMEM16A channel. In recent years, we and others have screened several natural modulators of TMEM16A against cancers and gastrointestinal motility dysfunction. This article reviews the screening methods, efficacy of TMEM16A modulators and pharmacological effects of TMEM16A modulators on different diseases. GRAPHIC ABSTACT.

Citing Articles

Tamsulosin ameliorates bone loss by inhibiting the release of Cl through wedging into an allosteric site of TMEM16A.

Li S, Sun W, Li S, Zhu L, Guo S, He J Proc Natl Acad Sci U S A. 2024; 122(1):e2407493121.

PMID: 39739807 PMC: 11725887. DOI: 10.1073/pnas.2407493121.

Modulatory Impact of Oxidative Stress on Action Potentials in Pathophysiological States: A Comprehensive Review.

Mahapatra C, Thakkar R, Kumar R Antioxidants (Basel). 2024; 13(10).

PMID: 39456426 PMC: 11504047. DOI: 10.3390/antiox13101172.

Discovery of Fungus-Derived Nornidulin as a Novel TMEM16A Inhibitor: A Potential Therapy to Inhibit Mucus Secretion in Asthma.

Pongkorpsakol P, Yimnual C, Satianrapapong W, Worakajit N, Kaewin S, Saetang P J Exp Pharmacol. 2023; 15:449-466.

PMID: 38026233 PMC: 10657771. DOI: 10.2147/JEP.S427594.

Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins.

Kunzelmann K, Ousingsawat J, Kraus A, Park J, Marquardt T, Schreiber R Int J Mol Sci. 2023; 24(17).

PMID: 37686084 PMC: 10487509. DOI: 10.3390/ijms241713278.

Identification of a drug binding pocket in TMEM16F calcium-activated ion channel and lipid scramblase.

Feng S, Puchades C, Ko J, Wu H, Chen Y, Figueroa E Nat Commun. 2023; 14(1):4874.

PMID: 37573365 PMC: 10423226. DOI: 10.1038/s41467-023-40410-x.

References

Acharya C, Coop A, Polli J, MacKerell Jr A . Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. Curr Comput Aided Drug Des. 2010; 7(1):10-22. PMC: 2975775. DOI: 10.2174/157340911793743547. View

Atala A . Re: Inhibition of Ca2+ -activated Cl- channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma. J Urol. 2013; 189(6):2393. DOI: 10.1016/j.juro.2013.02.107. View

Bajaj S, Ong S, Chandy K . Contributions of natural products to ion channel pharmacology. Nat Prod Rep. 2020; 37(5):703-716. DOI: 10.1039/c9np00056a. View

Barish M . A transient calcium-dependent chloride current in the immature Xenopus oocyte. J Physiol. 1983; 342:309-25. PMC: 1193960. DOI: 10.1113/jphysiol.1983.sp014852. View

Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S . Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc Natl Acad Sci U S A. 2013; 110(11):E1026-34. PMC: 3600458. DOI: 10.1073/pnas.1217072110. View

Brunner J, Lim N, Schenck S, Duerst A, Dutzler R . X-ray structure of a calcium-activated TMEM16 lipid scramblase. Nature. 2014; 516(7530):207-12. DOI: 10.1038/nature13984. View

Burris S, Wang Q, Bulley S, Neeb Z, Jaggar J . 9-Phenanthrol inhibits recombinant and arterial myocyte TMEM16A channels. Br J Pharmacol. 2015; 172(10):2459-68. PMC: 4409899. DOI: 10.1111/bph.13077. View

Wang Q, Gan H, Chen C, Sun Y, Chen J, Xu M . Identification and validation of a 44-gene expression signature for the classification of renal cell carcinomas. J Exp Clin Cancer Res. 2017; 36(1):176. PMC: 5717815. DOI: 10.1186/s13046-017-0651-9. View

Chai R, Chen Y, Yuan H, Wang X, Guo S, Qi J . Identification of Resveratrol, an Herbal Compound, as an Activator of the Calcium-Activated Chloride Channel, TMEM16A. J Membr Biol. 2017; 250(5):483-492. DOI: 10.1007/s00232-017-9975-9. View

10.

Contreras-Vite J, Cruz-Rangel S, De Jesus-Perez J, Figueroa I, Rodriguez-Menchaca A, Perez-Cornejo P . Revealing the activation pathway for TMEM16A chloride channels from macroscopic currents and kinetic models. Pflugers Arch. 2016; 468(7):1241-1257. PMC: 5556394. DOI: 10.1007/s00424-016-1830-9. View

11.

Cottreau J, Tucker A, Crutchley R, Garey K . Crofelemer for the treatment of secretory diarrhea. Expert Rev Gastroenterol Hepatol. 2011; 6(1):17-23. DOI: 10.1586/egh.11.87. View

12.

Danahay H, Lilley S, Fox R, Charlton H, Sabater J, Button B . TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis. Am J Respir Crit Care Med. 2020; 201(8):946-954. PMC: 7159426. DOI: 10.1164/rccm.201908-1641OC. View

13.

Dang S, Feng S, Tien J, Peters C, Bulkley D, Lolicato M . Cryo-EM structures of the TMEM16A calcium-activated chloride channel. Nature. 2017; 552(7685):426-429. PMC: 5750132. DOI: 10.1038/nature25024. View

14.

Davis A, Shi J, Pritchard H, Chadha P, Leblanc N, Vasilikostas G . Potent vasorelaxant activity of the TMEM16A inhibitor T16A(inh) -A01. Br J Pharmacol. 2012; 168(3):773-84. PMC: 3579294. DOI: 10.1111/j.1476-5381.2012.02199.x. View

15.

Deba F, Bessac B . Anoctamin-1 Cl(-) channels in nociception: activation by an N-aroylaminothiazole and capsaicin and inhibition by T16A[inh]-A01. Mol Pain. 2015; 11:55. PMC: 4567824. DOI: 10.1186/s12990-015-0061-y. View

16.

Dixit R, Kemp C, Kulich S, Seethala R, Chiosea S, Ling S . TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation. Sci Rep. 2015; 5:16657. PMC: 4643216. DOI: 10.1038/srep16657. View

17.

Galietta L, Haggie P, Verkman A . Green fluorescent protein-based halide indicators with improved chloride and iodide affinities. FEBS Lett. 2001; 499(3):220-4. DOI: 10.1016/s0014-5793(01)02561-3. View

18.

Guo S, Chen Y, Pang C, Wang X, Shi S, Zhang H . Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effects. J Cell Physiol. 2018; 234(6):8698-8708. DOI: 10.1002/jcp.27529. View

19.

Guo S, Wang H, Pang C, Ren X, Li J, Wang X . Entering the spotlight: Chitosan oligosaccharides as novel activators of CaCCs/TMEM16A. Pharmacol Res. 2019; 146:104323. DOI: 10.1016/j.phrs.2019.104323. View

20.

Guo S, Chen Y, Shi S, Wang X, Zhang H, Zhan Y . Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy. Pharmacol Res. 2020; 155:104721. DOI: 10.1016/j.phrs.2020.104721. View